Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.
about
Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.New p32/gC1qR Ligands for Targeted Tumor Drug Delivery.Tumor-penetrating peptides.Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity.Targeted silver nanoparticles for ratiometric cell phenotyping.Tumor-homing peptides as tools for targeted delivery of payloads to the placenta.Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.Tumor-Targeted Multimodal Optical Imaging with Versatile Cadmium-Free Quantum DotsNRP1 transport of cancer therapeutics mediated by tumor-penetrating peptides.Crossing the barrier: treatment of brain tumors using nanochain particles.Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles.Molecular dynamics, thermodynamic, and mutational binding studies for tumor-specific LyP-1 in complex with p32.Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis.Tumor-targeted delivery of siRNA using fatty acyl-CGKRK peptide conjugates.A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma.Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment.Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth.Targeted Delivery of siRNA Therapeutics to Malignant Tumors.Multi-functional, multicompartmental hyaluronan-binding protein 1 (HABP1/p32/gC1qR): implication in cancer progression and metastasis.Cell-penetrating peptide CGKRK mediates efficient and widespread targeting of bladder mucosa following focal injury.Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice.
P2860
Q33681168-7CC44F49-C249-4E30-A6C2-EC036E284063Q33694228-C5E427F4-3B02-4827-A262-C49D3C30C44FQ34976054-369E29B0-BA9C-4C58-B1C4-1F0050290247Q35395576-C2778758-BA2C-4ACD-BC9A-0763CD1B203AQ36849542-E33884A8-48CB-4FE6-A234-CA5619C7751AQ37056248-9B6C514E-7392-4FA5-B54C-E1AF010C1129Q37071560-FD1E1F90-6D99-410C-95AD-B742CEBAF57FQ37103119-9883D7AF-4EBB-462A-B31B-6F25256428F4Q38672213-5FF3DD53-90BF-4028-B5D9-7BFE0B02812CQ38691508-BBB8EC9C-1A3A-4B21-8300-3D0F31DC1C1EQ38731251-D88EE2D8-BCF3-4BE5-BB0B-5C1561FD4F36Q38828282-57066E44-9C03-4457-AC28-79C2533FBFC0Q39368829-096F40B5-8BA1-471C-86B8-32FFA75AEAB3Q41094538-61AAEBFA-29F3-4E99-9BB0-76B930A331ACQ42672085-59A20483-18E2-47DA-A8C6-BB1FDCF2CEEAQ45994556-4DB3FFAD-57B5-4E6E-AF07-052DC40CB3F9Q46039070-AAD1A392-7FC0-48F7-90B1-5F421AF24C2BQ47152520-AD380F49-4056-4DEF-977A-2220982F3CF3Q52356762-72594787-5143-49EC-A150-813807D5E7E8Q52680751-B6E17335-0677-461A-87B5-C7861D868FE7Q55267046-E6DF3C20-E9EB-4A85-B5AD-79BB5C2789AB
P2860
Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.
@en
Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.
@nl
type
label
Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.
@en
Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.
@nl
prefLabel
Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.
@en
Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.
@nl
P2093
P2860
P356
P1433
P1476
Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.
@en
P2093
Dinorah Friedmann-Morvinski
Kazuki N Sugahara
Lilach Agemy
Shweta Sharma
Venkata R Kotamraju
P2860
P304
P356
10.1038/MT.2013.191
P577
2013-08-20T00:00:00Z